Compositions and methods for treating surgical adhesions

Overview

Information

Number
6689803
Application
10/067467
Filing date
02/05/2002
Issue date
02/10/2004
Inventor(s)
William L. Hunter
US Classification
514/365
View at USPTO

Citations

Sanofi-aventis (10)
Bristol-Myers Squibb (5)
ALABAMA AT BIRMINGHAM, UNIVERSITY OF (5)
Angiotech International (4)
IPXMEDICAL, LLC (4)
Poly-Med (4)
Regents of the University of California, The (3)
Merrell Dow Pharmaceuticals (3)
NA (3)
The United States of America as represented by the Department of Health (2)
The Johns Hopkins University (2)
UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (2)
Pfizer (2)
Massachusetts Institute Of Technology (2)
Eisai Co. (2)
Children's Medical Center (2)
Thomas Jefferson University (2)
Vestar (1)
SPEED GEL (1)
Rhone-Poulenc Rorer (1)
Chemex Pharmaceuticals (1)
PG-TXL (1)
HOSTETLER, KARL Y. (1)
McGill University (1)
Hospira (1)
HOSTETLER FAMILY TRUST (1)
ANGIODEVICE INTERNATIONAL (1)
Tapestry Pharmaceuticals (1)
Procter & Gamble (1)
Regents Of The University of Minnesota (1)
Vertex Pharmaceuticals (1)
Advanced cardiovascular Systems (1)
COVALON technology (1)
Montana State University (1)
COOK MEDICAL TECHNOLOGIES (1)
Phanos Technologies (1)
Chimerix (1)
Matrix Pharmaceutical (1)
Celgene (1)
AMO UPPSALA AB (1)

Abstract

Abstract

Methods and compositions for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis are provided, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.

Assignees with Similar Patents

Angiotech International (19)
PG-TXL (12)
IPXMEDICAL, LLC (8)
ANGIODEVICE INTERNATIONAL (5)
Samyang (5)

Referenced by

Boston Scientific (38)
conextions (19)
CritiTech (18)
broncus medical (16)
Celgene (12)
dfb soria (7)
University of Utah (5)
SurModics (4)
resurge therapeutics (4)
Broncus Technologies (2)
ROCHE DIAGNOSTICS HEMATOLOGY, INC. (2)
Cardiac Pacemakers (2)
Covidien (2)
Industrial Technology research Institute (2)
COOK MEDICAL TECHNOLOGIES (2)
SWEET, RICHARD M. (2)
Otago Innovation (1)
UNIVERSITY OF BRITISH COLUMBIA, THE (1)
critltech (1)
Omeros (1)
Bristol-Myers Squibb (1)
Abbott Laboratories (1)
University of Kentucky Research Foundation (1)
dfb soria ll (1)
Remon Medical Technologies (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
514 365 Emerging Sustaining Seminal Medium Average 40.7